rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2007-7-3
|
pubmed:abstractText |
Cytokine-induced killer (CIK) cells have shown anti-leukemic activity and little graft-versus-host disease (GVHD) in several animal models. The safety of these cells in autologous settings has been shown. We performed a phase I study of allogeneic (donor's) CIK cells in patients relapsing after allogeneic haematopoietic stem cell transplantation (HSCT).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1592-8721
|
pubmed:author |
pubmed-author:BarbuiAnna MariaAM,
pubmed-author:BarbuiTizianoT,
pubmed-author:BaroncianiDonatellaD,
pubmed-author:BiagiEttoreE,
pubmed-author:BiondiAndreaA,
pubmed-author:BorleriGianmariaG,
pubmed-author:BroadyRaewynR,
pubmed-author:ContiElenaE,
pubmed-author:D'AmicoGiovannaG,
pubmed-author:DanderEricaE,
pubmed-author:FranceschettiMartaM,
pubmed-author:GaipaGiuseppeG,
pubmed-author:GolayJoséeJ,
pubmed-author:GrassiAnnaA,
pubmed-author:IntronaMartinoM,
pubmed-author:ParmaMatteoM,
pubmed-author:PoglianiEnrico MEM,
pubmed-author:RambaldiAlessandroA,
pubmed-author:SpinelliOriettaO
|
pubmed:issnType |
Electronic
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
952-9
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17606446-Adult,
pubmed-meshheading:17606446-Cytokines,
pubmed-meshheading:17606446-Female,
pubmed-meshheading:17606446-Hematologic Neoplasms,
pubmed-meshheading:17606446-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:17606446-Humans,
pubmed-meshheading:17606446-Killer Cells, Natural,
pubmed-meshheading:17606446-Lymphocyte Transfusion,
pubmed-meshheading:17606446-Male,
pubmed-meshheading:17606446-Middle Aged,
pubmed-meshheading:17606446-Recurrence,
pubmed-meshheading:17606446-Salvage Therapy,
pubmed-meshheading:17606446-Transplantation, Homologous
|
pubmed:year |
2007
|
pubmed:articleTitle |
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study.
|
pubmed:affiliation |
Laboratory of Cellular and Gene Therapy G. Lanzani, Ospedali Riuniti di Bergamo, Bergamo, Italy. mintrona@ospedaliriuniti.bergamo.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|